Log In
BCIQ
Print this Print this
 

pradefovir, mesylate

Also known as: Hepavir B (formerly MB06866, Remofovir)

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionProdrug of PMEA, an antiviral compound
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat chronic hepatitis B virus (HBV) infection; Treat hepatitis B virus (HBV) infection
Regulatory Designation
PartnerHainan Kaihua Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$3.2M

$2.6M

$101.6M


 Deals Details
Get a free BioCentury trial today